IDEAS home Printed from https://ideas.repec.org/a/nat/natcom/v8y2017i1d10.1038_s41467-017-00578-5.html
   My bibliography  Save this article

The non-canonical poly(A) polymerase FAM46C acts as an onco-suppressor in multiple myeloma

Author

Listed:
  • Seweryn Mroczek

    (University of Warsaw
    Institute of Biochemistry and Biophysics, Polish Academy of Sciences)

  • Justyna Chlebowska

    (University of Warsaw
    Medical University of Warsaw
    University of Warsaw
    Medical University of Warsaw)

  • Tomasz M. Kuliński

    (Institute of Biochemistry and Biophysics, Polish Academy of Sciences)

  • Olga Gewartowska

    (University of Warsaw
    Institute of Biochemistry and Biophysics, Polish Academy of Sciences)

  • Jakub Gruchota

    (Institute of Biochemistry and Biophysics, Polish Academy of Sciences
    International Institute of Molecular and Cell Biology)

  • Dominik Cysewski

    (Institute of Biochemistry and Biophysics, Polish Academy of Sciences)

  • Vladyslava Liudkovska

    (University of Warsaw)

  • Ewa Borsuk

    (University of Warsaw)

  • Dominika Nowis

    (University of Warsaw
    Medical University of Warsaw)

  • Andrzej Dziembowski

    (University of Warsaw
    Institute of Biochemistry and Biophysics, Polish Academy of Sciences)

Abstract

FAM46C is one of the most frequently mutated genes in multiple myeloma. Here, using a combination of in vitro and in vivo approaches, we demonstrate that FAM46C encodes an active non-canonical poly(A) polymerase which enhances mRNA stability and gene expression. Reintroduction of active FAM46C into multiple myeloma cell lines, but not its catalytically-inactive mutant, leads to broad polyadenylation and stabilization of mRNAs strongly enriched with those encoding endoplasmic reticulum-targeted proteins and induces cell death. Moreover, silencing of FAM46C in multiple myeloma cells expressing WT protein enhance cell proliferation. Finally, using a FAM46C-FLAG knock-in mouse strain, we show that the FAM46C protein is strongly induced during activation of primary splenocytes and that B lymphocytes isolated from newly generated FAM46C KO mice proliferate faster than those isolated from their WT littermates. Concluding, our data clearly indicate that FAM46C works as an onco-suppressor, with the specificity for B-lymphocyte lineage from which multiple myeloma originates.

Suggested Citation

  • Seweryn Mroczek & Justyna Chlebowska & Tomasz M. Kuliński & Olga Gewartowska & Jakub Gruchota & Dominik Cysewski & Vladyslava Liudkovska & Ewa Borsuk & Dominika Nowis & Andrzej Dziembowski, 2017. "The non-canonical poly(A) polymerase FAM46C acts as an onco-suppressor in multiple myeloma," Nature Communications, Nature, vol. 8(1), pages 1-17, December.
  • Handle: RePEc:nat:natcom:v:8:y:2017:i:1:d:10.1038_s41467-017-00578-5
    DOI: 10.1038/s41467-017-00578-5
    as

    Download full text from publisher

    File URL: https://www.nature.com/articles/s41467-017-00578-5
    File Function: Abstract
    Download Restriction: no

    File URL: https://libkey.io/10.1038/s41467-017-00578-5?utm_source=ideas
    LibKey link: if access is restricted and if your library uses this service, LibKey will redirect you to where you can use your library subscription to access this item
    ---><---

    Citations

    Citations are extracted by the CitEc Project, subscribe to its RSS feed for this item.
    as


    Cited by:

    1. Michał Brouze & Agnieszka Czarnocka-Cieciura & Olga Gewartowska & Monika Kusio-Kobiałka & Kamil Jachacy & Marcin Szpila & Bartosz Tarkowski & Jakub Gruchota & Paweł Krawczyk & Seweryn Mroczek & Ewa Bo, 2024. "TENT5-mediated polyadenylation of mRNAs encoding secreted proteins is essential for gametogenesis in mice," Nature Communications, Nature, vol. 15(1), pages 1-20, December.
    2. Yandan Yang & Arnold Bolomsky & Thomas Oellerich & Ping Chen & Michele Ceribelli & Björn Häupl & George W. Wright & James D. Phelan & Da Wei Huang & James W. Lord & Callie K. Winkle & Xin Yu & Jan Wis, 2022. "Oncogenic RAS commandeers amino acid sensing machinery to aberrantly activate mTORC1 in multiple myeloma," Nature Communications, Nature, vol. 13(1), pages 1-19, December.

    More about this item

    Statistics

    Access and download statistics

    Corrections

    All material on this site has been provided by the respective publishers and authors. You can help correct errors and omissions. When requesting a correction, please mention this item's handle: RePEc:nat:natcom:v:8:y:2017:i:1:d:10.1038_s41467-017-00578-5. See general information about how to correct material in RePEc.

    If you have authored this item and are not yet registered with RePEc, we encourage you to do it here. This allows to link your profile to this item. It also allows you to accept potential citations to this item that we are uncertain about.

    We have no bibliographic references for this item. You can help adding them by using this form .

    If you know of missing items citing this one, you can help us creating those links by adding the relevant references in the same way as above, for each refering item. If you are a registered author of this item, you may also want to check the "citations" tab in your RePEc Author Service profile, as there may be some citations waiting for confirmation.

    For technical questions regarding this item, or to correct its authors, title, abstract, bibliographic or download information, contact: Sonal Shukla or Springer Nature Abstracting and Indexing (email available below). General contact details of provider: http://www.nature.com .

    Please note that corrections may take a couple of weeks to filter through the various RePEc services.

    IDEAS is a RePEc service. RePEc uses bibliographic data supplied by the respective publishers.